Global Avascular Necrosis Market Research Report By Type (Trauma Related Avascular Necrosis (AVN) and Non-Trauma Related Avascular Necrosis (AVN), By Site (Hip Bone, Knee, Shoulder and Other), By Diagnosis(Imaging, Biopsy, Total, CT Scan, PET and X- Ray), By Treatment (Medication, Electrical Stimulation, Gene Therapy and Surgery), By End-User(Hospitals & Clinics, Diagnostic Centers and Ambulatory Surgical Centers), By Region — Forecast to 2024.
Market Leading Players
Integra LifeSciences Corporation, Bayer AG, Eli Lilly and Company, Bristol-Myers Squibb, Medtronic Plc, Merck KGaA, Sanofi, Zimmer Biomet Holdings, Pfizer Inc, Boehringer Ingelheim.
Global Avascular Necrosis Market Overview
Avascular necrosis (AVN) is a bone disorder which occurs when bone tissue begins to die owing to the insufficient supply of blood. Avascular necrosis is often caused by joint or bone trauma, long-term steroid use, or prolonged alcohol abuse. In the state-of-the-art report published by Market Research Future (MRFR), the global avascular necrosis market is stated to expand at a lucrative CAGR of 6.58% during the forecast period.
Detailed Regional Analysis
is regionally segmented into North America, Latin America, Europe, Asia Pacific (APAC,) and the Middle East & Africa (MEA). The Americas are anticipated to lead the global avascular necrosis market owing to the concentration of market players in the region. An affinity towards the adoption of technically advanced medical treatments and practices has promoted regional growth in the region. The U.S. and Canada are likely to spearhead the country-specific market in the region during the forecast period. Asia Pacific is projected to inflate at the highest CAGR during the forecast period owing to the increasing prevalence of the disorder in the emerging economies present in the region. Manufacturing of medical devices is observed to increasingly shift to developing countries such as India and China owing to lower labor costs and lower investments necessary to set up the infrastructure.
Key Questions Answered in This Report:
· What will the market size and what will the growth rate be?
· What are the key market trends?
· What is driving this market?
· What are the challenges to market growth?
· Who are the key vendors in this market space?
· What are the market opportunities and threats faced by the key vendors?
Table Of Content
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.2. Scope of the Study
2.2.1. Research Objective
3. RESEARCH METHODOLOGY
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
Get Discount @
August 2018: Renowned orthopedic surgeon Dr. Amarnath Surath announced the launch of Centre for Regenerative Medicine (CRM). Right before the launch, the surgeon completed trial runs of his newly launched PRP kit, which aims at not only relieving patients of joint pain but also, bypass surgical replacement of joints. The CRM is also actively involved in the treatment of fracture non-unions and avascular necrosis of the hip.
Browse other healthcare-related reports
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.